financetom
Business
financetom
/
Business
/
Some US lawmakers call for more scrutiny of news app NewsBreak over Chinese origins
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Some US lawmakers call for more scrutiny of news app NewsBreak over Chinese origins
Jun 8, 2024 10:08 AM

WASHINGTON/LONDON (Reuters) -Three U.S. lawmakers have called for more scrutiny of NewsBreak, a popular news aggregation app in the United States, after Reuters reported it has Chinese origins and has used artificial intelligence tools to produce erroneous stories.

The Reuters story drew upon previously unreported court documents related to copyright infringement, cease-and-desist emails, and a 2022 company memo registering concerns about "AI-generated stories" to identify at least 40 instances in which NewsBreak's use of AI tools affected the communities it strives to serve.

"The only thing more terrifying than a company that deals in unchecked, artificially generated news, is one with deep ties to an adversarial foreign government," said Senator Mark Warner, a Democrat who chairs the Intelligence Committee.

"This is yet another example of the serious threat posed by technologies from countries of concern. It's also a stark reminder that we need a holistic approach to addressing this threat - we simply cannot win the game of whack-a-mole with individual companies," he said. 

The lawmakers expressed concerns about NewsBreak's current and historical links to Chinese investors, and the company's presence in China, where many of its engineers are based.     

In response to a request from Reuters for comment about the lawmakers' statements, NewsBreak said it was an American company: "NewsBreak is a U.S. company and always has been. Any assertion to the contrary is not true," a spokesperson said.

NewsBreak launched in the U.S. in 2015 as a subsidiary of Yidian, a Chinese news aggregation app. Both companies were founded by Jeff Zheng, the CEO of NewsBreak, and the companies share a U.S. patent registered in 2015 for an "Interest Engine" algorithm, which recommends news content based on a user's interests and location, Reuters reported.

Yidian in 2017 received praise from ruling Communist Party officials in China for its efficiency in disseminating government propaganda. Reuters found no evidence that NewsBreak censored or produced news that was favourable to the Chinese government.

"This report brings to light serious questions about Newsbreak, its historical relationship with an entity that assisted the CCP, and to Chinese state-linked media," said Representative Raja Krishnamoorthi, the top Democrat on the House select committee on China, in a reference to Yidian and its former investor, state-linked media outlet Phoenix New Media. 

Americans have the right to "full transparency" about any connections to the CCP from news distributors, Krishnamoorthi added, particularly with regards to the use of "opaque algorithms" and artificial intelligence tools to produce news.

Reuters reported the praise Yidian received from the Communist Party in 2017, but was unable to establish that NewsBreak has any current ties with the Party.

U.S. Representative Elise Stefanik, a Republican, said IDG Capital's backing of NewsBreak indicated the app "deserves increased scrutiny." 

"We cannot allow our foreign adversaries access to American citizen's data to weaponize them against America's interests," she said.

NewsBreak is a privately held start-up, whose primary backers are private equity firms San Francisco-based Francisco Partners and Beijing-based IDG Capital, Reuters reported. In February, IDG Capital was added to a list of dozens of Chinese companies the Pentagon said were allegedly working with Beijing's military.

IDG Capital has previously said it has no association with the Chinese military and does not belong on that list. It declined to comment on the lawmaker's reaction.

A spokesperson for Francisco Partners, which has previously declined to answer questions from Reuters on their investment in NewsBreak, described the story as "false and misleading," but declined to provide details beyond saying the description of them as a "primary backer" of NewsBreak was incorrect because their investment was less than 10%.

They did not provide documentation to prove the size of the holding. NewsBreak has told Reuters as recently as May 13 that Francisco Partners is NewsBreak's primary investor. NewsBreak did not respond to two requests late Friday asking for documentation supporting the assertion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Copyright 2023-2026 - www.financetom.com All Rights Reserved